LPL Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
67,193
+42,288
| +170% | +$1.01M | ﹤0.01% | 3308 |
|
|
2025
Q1 | $619K | Buy |
24,905
+11,584
| +87% | +$288K | ﹤0.01% | 3920 |
|
|
2024
Q4 | $251K | Buy |
+13,321
| New | +$251K | ﹤0.01% | 4563 |
|
|
2024
Q3 | – | Sell |
-7,464
| Closed | -$214K | – | 5137 |
|
|
2024
Q2 | $214K | Buy |
+7,464
| New | +$214K | ﹤0.01% | 4428 |
|
|
2024
Q1 | – | Sell |
-6,448
| Closed | -$218K | – | 4908 |
|
|
2023
Q4 | $218K | Buy |
+6,448
| New | +$218K | ﹤0.01% | 4269 |
|
|
2023
Q1 | – | Sell |
-6,113
| Closed | -$236K | – | 4526 |
|
|
2022
Q4 | $236K | Sell |
6,113
-689
| -10% | -$26.6K | ﹤0.01% | 3830 |
|
|
2022
Q3 | $362K | Sell |
6,802
-689
| -9% | -$36.7K | ﹤0.01% | 3402 |
|
|
2022
Q2 | $437K | Buy |
7,491
+77
| +1% | +$4.49K | ﹤0.01% | 3303 |
|
|
2022
Q1 | $566K | Buy |
7,414
+161
| +2% | +$12.3K | ﹤0.01% | 3087 |
|
|
2021
Q4 | $436K | Buy |
7,253
+1,033
| +17% | +$62.1K | ﹤0.01% | 3386 |
|
|
2021
Q3 | $348K | Buy |
6,220
+649
| +12% | +$36.3K | ﹤0.01% | 3514 |
|
|
2021
Q2 | $338K | Buy |
5,571
+2,101
| +61% | +$127K | ﹤0.01% | 3483 |
|
|
2021
Q1 | $243K | Buy |
+3,470
| New | +$243K | ﹤0.01% | 3601 |
|
|
2016
Q1 | – | Sell |
-2,968
| Closed | -$221K | – | 3180 |
|
|
2015
Q4 | $221K | Buy |
+2,968
| New | +$221K | ﹤0.01% | 2751 |
|
|
2014
Q3 | – | Sell |
-10,393
| Closed | -$955K | – | 2765 |
|
|
2014
Q2 | $955K | Buy |
+10,393
| New | +$955K | 0.01% | 1359 |
|